The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czec... von Jindra, P, Muzik, J, Indrak, K, Zak, P, Sabty, F A, Kozak, T, Cetkovsky, P, Karas, V Koza M, Raida, L, Szotkowski, T

Volltext

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label,... von Finke, Jürgen, Prof, Bethge, Wolfgang A, MD, Schmoor, Claudia, PhD, Ottinger, Hellmut D, MD, Stelljes, Matthias, MD, Zander, Axel R, Prof, Volin, Liisa, MD, Ruutu, Tapani, MD, Heim, Dominik A, MD, Schwerdtfeger, Rainer, Prof, Kolbe, Karin, MD, Mayer, Jiri, Prof, Maertens, Johan A, MD, Linkesch, Werner, Prof, Holler, Ernst, Prof, Koza, Vladimir, Prof, Bornhäuser, Martin, Prof, Einsele, Hermann, Prof, Kolb, Hans-Jochem, Prof, Bertz, Hartmut, Prof, Egger, Matthias, MD, Grishina, Olga, MD, Socié, Gérard, Prof

Volltext

Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU MEL conditioning regimen in context with BU CY2 von Vokurka, S, Steinerova, K, Karas, M, Koza, V

Volltext

Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu Mel conditioning allo-SCT von Vokurka, S, Svoboda, T, Jungova, A, Karas, M, Koza, V

Volltext

Spontaneous remission of acute myeloid leukemia - a single center case reports von Pachner, M, Vokurka, S, Koza, V, Svoboda, T, Hrabětová, M, Jindra, P, Lysák, D, Vozobulová, V, Schutzova, M, Karas, M

Volltext

Favourable outcome of allogeneic stem cell transplantation for patients with intermediate-risk AML in 1.CR--A single-centre experience from 2003-2008 von Karas, M, Steinerova, K, Jindra, P, Lysak, D, Vokurka, S, Svoboda, T, Mohammad, L, Koza, V

Volltext

Outcomes of the patients with myelodysplastic syndrome, acute myeloid leukaemia with multilineage dysplasia and treatment-related acute myeloid leukaemia after allogeneic stem cell... von Steinerova, K, Koza, V, Jindra, P, Lysak, D, Karas, M, Svoboda, T

Volltext

No benefit of autologous stem cell transplantation as consolidation for high and high-intermediate risk diffuse large B-cell lymphoma in 1.CR after R-CHOP therapy--a single-centre... von Karas, M, Steinerova, K, Jindra, P, Lysak, D, Vokurka, S, Vozobulova, V, Schutzova, M, Mohammadova, L, Koza, V

Volltext

Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with auto... von Jindra, P, Koza, V, Boudová, L, Vozobulová, V, Černá, K, Karas, M, Lysák, D, Švojgrová, M

Volltext

Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial von Finke, Jürgen, Schmoor, Claudia, Bethge, Wolfgang A, Ottinger, Hellmut D, Stelljes, Matthias, Zander, Axel R, Volin, Liisa, Heim, Dominik A, Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A, Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Bertz, Hartmut, Grishina, Olga, Socié, Gérard

Volltext

Allogeneic BMT in patients above 45 years of age : a single center experience von LYSAK, D, KOZA, V, VOKURKA, S, JINDRA, P, VOZOBULOVA, V, SCHUTZOVA, M, FISER, J, CERNA, K, KARAS, M, SKOPEK, P, SVOJGROVA, M

Volltext